Pakistan court frees eight men charged with attack on schoolgirl

A Pakistani court has freed eight out of 10 men charged with organizing the shooting of schoolgirl activist Malala Yousafzai, police said on Friday, a move that will raise further questions about the nation’s heavily criticized justice system. Pakistani Taliban militants claimed responsibility for attacking Malala in 2012 as she traveled home from school in…

7 Steps To Evaluate A Financial Advisor

Choosing the right financial advisor for your unique situation is not an easy task. Recommendations from a friend or business colleague can be a good source, but remember the right advisor for one person may not be a good fit for your needs. Here are seven steps to take in evaluating either a new financial…

The sales cycle on steroids: 3 ways analytics power up revenue

This article is part of DBA, a series on Mashable about running a business that features insights from leaders in entrepreneurship, venture capital and management. Over the last 10 years, marketing has experienced a technology revolution. CMOs target, attract, engage and create loyalty by leveraging everything from marketing automation platforms to sophisticated big data and…

Tom Brady Inspiration: To Achieve Your Goals, NO Distractions

Businesses set long-term goals they strive to achieve and here is the optimal method for doing so. Listen to New England Patriots’ Quarterback Tom Brady and… 1) When Achieving Your Goals, Eliminate Distractions To not get distracted from achieving your goals created in the business plan, businesses have to remember to maintain focus and increase concentration. Distractions are where a business plan…

Verizon barges into online video, buying AOL for $4.4B

NEW YORK (AP) — Verizon is buying AOL for about $4.4 billion, advancing the telecom’s push in both mobile and advertising fields. The acquisition gives Verizon an entry into increasingly competitive online and mobile video. The New York company is the country’s largest wireless carrier as well as an Internet and TV provider — and…

Novel Drug From Nature Shows Early Promise

A biotechnology company developing an unusual drug—derived from the venom of a sea anemone to treat autoimmune diseases such as psoriasis and multiple sclerosis—reported encouraging results from a phase 1 clinical trial. Seattle-based Kineta Inc. said it expects early next year to begin recruiting patients for the next stage of the drug’s development, a phase…